Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Inventory (2022 - 2026)

Lucid Diagnostics filings provide 4 years of Inventory readings, the most recent being $353000.0 for Q4 2025.

  • On a quarterly basis, Inventory rose 3.52% to $353000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $353000.0, a 3.52% increase, with the full-year FY2025 number at $353000.0, up 3.52% from a year prior.
  • Inventory hit $353000.0 in Q4 2025 for Lucid Diagnostics, down from $486000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $683000.0 in Q2 2024 to a low of $111000.0 in Q4 2022.
  • Median Inventory over the past 4 years was $447000.0 (2024), compared with a mean of $430200.0.
  • Biggest five-year swings in Inventory: skyrocketed 150.45% in 2023 and later fell 26.06% in 2025.
  • Lucid Diagnostics' Inventory stood at $111000.0 in 2022, then surged by 150.45% to $278000.0 in 2023, then grew by 22.66% to $341000.0 in 2024, then grew by 3.52% to $353000.0 in 2025.
  • The last three reported values for Inventory were $353000.0 (Q4 2025), $486000.0 (Q3 2025), and $505000.0 (Q2 2025) per Business Quant data.